Overview
CBD and other hemp-derived products being marketed and sold as foods and dietary supplements are widely available for both human and pet use, despite the fact that the vast majority of these products are illegal at the federal level. Although largely anecdotal evidence shows promise for hemp and CBD products to treat various conditions in pets, many questions remain about safety and efficacy of these products. In addition, if companies decide to market these products, there is associated risk regarding any health-related claims. This webinar will explore the FDA regulatory status of hemp-derived products intended for use in pets, the current state of research regarding benefits, side effects, interaction with other substances, and overall toxicity, and how to minimize the risk of enforcement action regarding claims and other labeling issues.
Get Access
- +$100 for nonmembers
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Speakers
Bill Bookout, President, National Animal Supplement Council
Isaac Cheng, US Compliance, Canopy Growth Corporation
Jeannie M. Perron, Partner, Covington & Burling LLP
Moderated by Nancy E. Halpern, Partner, Fox Rothschild LLP
JEANNIE PERRON is a partner in Covington & Burling LLP’s Food and Drug Practice Group. In addition to being an attorney, Dr. Perron also holds a degree in veterinary medicine and has practiced as a veterinarian. Dr. Perron specializes in food and drug law, and advises clients in the regulation of dietary supplements, over-the-counterdrugs, cosmetics for humans, and import and export of products regulated by the United States Food and Drug Administration, as well as those having animal or microbially-derived ingredients regulated by USDA. Dr. Perron has a sub-specialty in animal food and drug law, advising companies that manufacture feed, feed ingredients, drugs, biologics and medical devices for animals, as well as clients in related industries.
is a registered patent attorney, Chair of the firm’s Animal Law Practice, and is a licensed veterinarian in the State ofNew Jersey. Dr. Halpern represents animal owners, animal-related businesses, veterinarians, biomedical research facilities, veterinarian pharmaceuticals, farmers and trade associations in issues related to the complex patchwork of local, state and federal laws and regulations governing corporate law, intellectual property, food and drug law, as well as animal health and the humane use of animals. Dr. Halpern capitalizes on her prior experience in veterinary medicine for the benefit of her current clients, which included serving as Director of the Division of Animal Health for the New Jersey Department of Agriculture and New Jersey’s State Veterinarian and served on the State Board of Veterinary Medicine Examiners (SBVME) for nearly a decade. Whether prepping and defending witnesses for trial or administrative actions, Dr. Halpern has appeared in courts from municipal court to the US Supreme Court and before a multitude of state and federal agencies. She also provides statutory and regulatory analysis for trade associations and animal-related businesses and represents businesses, from farms to pharmaceutical companies, during their interactions with governmental regulators.Virtual Learning FAQ
Related Content
